# Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse

> **NCT00373503** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 8 (actual)

## Conditions studied

- Marijuana Dependence

## Interventions

- **DRUG:** Lofexidine
- **DRUG:** dronabinol
- **DRUG:** Marijuana

## Key facts

- **NCT ID:** NCT00373503
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-06
- **Final completion:** 2008-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373503, "Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00373503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*